Litcius/Paper detail

Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes

Philippe Gautret, Van Thuan Hoang, Jean‐Christophe Lagier, Didier Raoult

2021International Journal of Antimicrobial Agents31 citationsDOIOpen Access PDF

Topics & Concepts

HydroxychloroquineAzithromycinMedicineRandomized controlled trialCoronavirus disease 2019 (COVID-19)Clinical trialOpen labelInternal medicineIntensive care medicineAntibioticsBiologyInfectious disease (medical specialty)MicrobiologyDiseaseCOVID-19 Clinical Research StudiesVitamin C and Antioxidants ResearchLong-Term Effects of COVID-19
Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes | Litcius